Ozempic maker struggles as it loses ground to rivals in weight-loss market
Novo Nordisk cuts sales and profit forecasts as it continues to lose ground to Mounjaro firm Eli Lilly The maker of Ozempic and Wegovy has cut its sales and profit forecasts as it continues to fall behind in the competitive market for obesity and diabetes treatments. Novo Nordisk’s chief (…)
Site référencé:
The Guardian (South&CentralAsia)
2847.jpg?width=140&quality=85&auto=format&fit=max&s=6294b6e1775d2a17950bf012b978e85a, 2847.jpg?width=460&quality=85&auto=format&fit=max&s=8d07e42f8ba690d3879851340f11f6eb, 2847.jpg?width=700&quality=85&auto=format&fit=max&s=0e2d0a82e6ad2e53e2b962b0aa290d0a
The Guardian (South&CentralAsia)
Mediocre movies, millions in taxpayer cash : how scores of films from low-profile UK producers were funded mainly by public money
5/11/2025
Drax power plant to go on earning ‘over £1m a day’ from burning wood pellets
5/11/2025
Why the anger with Billie Eilish ? Because it’s against the rules to say what we all know about billionaires | Zoe Williams
5/11/2025
Air safety officials to investigate deadly UPS cargo plane crash near Kentucky airport
5/11/2025
The best home gifts in the UK : 29 inspiring ideas for Christmas and beyond
5/11/2025
Who is Joe Marler ? From hair-raising rugby antics to breakout star of Celebrity Traitors
5/11/2025